Crescent Capital/$CCAP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Crescent Capital
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.
Ticker
$CCAP
Sector
Primary listing
Employees
-
Headquarters
Website
Crescent Capital Metrics
BasicAdvanced
$575M
13.07
$1.19
0.60
$1.90
1.29%
Price and volume
Market cap
$575M
Beta
0.6
52-week high
$18.57
52-week low
$13.54
Average daily volume
201K
Dividend rate
$1.90
Financial strength
Current ratio
1.311
Quick ratio
0.86
Long term debt to equity
122.437
Total debt to equity
122.437
Dividend payout ratio (TTM)
162.76%
Interest coverage (TTM)
2.34%
Profitability
Gross margin (TTM)
100.00%
Net profit margin (TTM)
24.12%
Operating margin (TTM)
76.54%
Effective tax rate (TTM)
3.61%
Management effectiveness
Return on assets (TTM)
5.27%
Return on equity (TTM)
5.98%
Valuation
Price to earnings (TTM)
13.073
Price to revenue (TTM)
3.14
Price to book
0.79
Price to tangible book (TTM)
0.79
Price to free cash flow (TTM)
8.801
Free cash flow yield (TTM)
11.36%
Free cash flow per share (TTM)
1.763
Dividend yield (TTM)
12.24%
Forward dividend yield
1.29%
Growth
Revenue change (TTM)
-7.22%
Earnings per share change (TTM)
-56.80%
3-year revenue growth (CAGR)
21.25%
3-year earnings per share growth (CAGR)
-7.55%
3-year dividend per share growth (CAGR)
0.81%
Bulls say / Bears say
The board approved a $20 million share buyback program to repurchase shares trading below NAV, signaling management’s confidence in the company’s intrinsic value and providing support against large discounts (Reuters).
As of March 31, 2025, 97.2% of CCAP’s debt investments carried floating rates, aligning asset yields with prevailing interest rates and helping to protect net interest income amid rate volatility (Reuters).
Wall Street analysts have a consensus “buy” rating on CCAP, with five buy ratings and one hold, and a median 12-month price target of $20.00, representing roughly 28% upside from current levels (Reuters).
Crescent Capital BDC’s first-quarter 2025 results showed adjusted EPS of $0.45, missing the consensus estimate of $0.52. Revenue dropped 16.3% year-over-year to $42.13 million, signaling weaker income generation from its core lending portfolio (Reuters).
In the second quarter of 2025, the company again fell short of expectations, reporting EPS of $0.46 against a forecast of $0.47. Revenue declined 12.2% year-over-year to $42.99 million, highlighting ongoing revenue contraction and margin pressure (Reuters).
Raymond James lowered its price target on CCAP from $20.00 to $17.00 following disappointing fourth-quarter results, pointing to limited near-term upside and raising concerns about the wind-down of its Logan JV and emerging credit risks (Investing.com).
Data summarised monthly by Lightyear AI. Last updated on 6 Sept 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Sept30
Crescent Capital
DividendEx-dividend
Oct15
Crescent Capital
DividendPayment
$0.42Per share
FAQs
What’s the current market cap for Crescent Capital stock?
Crescent Capital (CCAP) has a market cap of $575M as of September 16, 2025.
What is the P/E ratio for Crescent Capital stock?
The price to earnings (P/E) ratio for Crescent Capital (CCAP) stock is 13.07 as of September 16, 2025.
Does Crescent Capital stock pay dividends?
Yes, the Crescent Capital (CCAP) stock pays dividends to shareholders. As of September 16, 2025, the dividend rate is $1.9 and the yield is 1.29%. Crescent Capital has a payout ratio of 162.76% on a trailing twelve-month basis.
When is the next Crescent Capital dividend payment date?
The next Crescent Capital (CCAP) dividend payment is scheduled for October 15, 2025.
What is the beta indicator for Crescent Capital?
Crescent Capital (CCAP) has a beta rating of 0.6. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.